Pharmacotherapy for neonatal seizures: current knowledge and future perspectives
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.
M Donovan, B Griffin, L Kharoshankaya, J Cryan… - Drugs, 2016 - search.ebscohost.com
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
[PDF][PDF] Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - 2016 - academia.edu
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
MD Donovan, BT Griffin, L Kharoshankaya… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - Drugs, 2016 - search.proquest.com
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
Pharmacotherapy for neonatal seizures: current knowledge and future perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - 2016 - cora.ucc.ie
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
[PDF][PDF] Pharmacotherapy for neonatal seizures: current knowledge and future
MD Donovan, BT Griffin, L Kharoshankaya… - is available at Springer …, 2016 - core.ac.uk
Downloaded on 2018-08-23T19:24:21Z Page 1 Title Pharmacotherapy for neonatal seizures:
current knowledge and future perspectives Author(s) Donovan, Maria D.; Griffin, Brendan T.; …
current knowledge and future perspectives Author(s) Donovan, Maria D.; Griffin, Brendan T.; …
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - Drugs, 2016 - europepmc.org
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
[引用][C] Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - Drugs, 2016 - cir.nii.ac.jp
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives
MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan… - Drugs, 2016 - infona.pl
Seizures are the most common neurological emergencies in the neonatal period and are
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …
associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 …